Jefferson University Hospitals

Provider Profile

Kevin D. Judy, MD

Jefferson University Physician

Academic Title: Professor

Neurosurgery - Neuro-Oncologic & Stereotactic

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

909 Walnut Street
2nd Floor, COB Bldg.
Philadelphia PA 19107
Phone: (215) 955-7000
Fax: (215) 503-9357

Medical Services

Board Certifications

  • Neurological Surgery

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital

Awards and Honors

Philadelphia Magazine's Top Docs 2016,2015,2014,2013,2012,2011


  • University of Pittsburgh School of Medicine, Medical School


  • Mercy Hospital of Pittsburgh


  • Johns Hopkins University Hospital
  • Mercy Hospital of Pittsburgh


  • Johns Hopkins University Hospital

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • Aetna
  • Aetna PA Employee Benefit Trust Fund (PEBTF)
  • Amerihealth 65
  • AmeriHealth HMO
  • AmeriHealth Personal Choice
  • Berkshire Health Partners
  • Blue Choice
  • Blue Cross/Blue Shield
  • Cigna Healthspring
  • Cigna PPO, POS
  • Consumer Health Network PPO
  • CorVel
  • Devon
  • Employers Health Network PPO
  • Evolutions (Guardian Resources)
  • First Health Network
  • Fortified Provider Network
  • Galaxy
  • Geisinger Health Plan
  • Health America PPO
  • Health Management Network PPO
  • Horizon Blue Cross/Blue Shield
  • Horizon HMO
  • HumanaChoicePPO,Medicare,GoldPlusHMO
  • Intergroup Preferred
  • Jeff Plus
  • Keystone 65 HMO
  • Keystone First VIP Choice
  • Keystone First/Connect
  • Keystone Health Plan East
  • Medicaid of PA
  • Medicare
  • Mercy LIFE
  • MultiPlan Inc.
  • One Net PPO
  • Oxford of PA
  • Personal Choice (GPPPN)
  • Personal Choice 65
  • PlanCare America
  • Preferred Care PPO
  • Premier Blue
  • Prime Health Services, Inc.
  • Provider Select Inc
  • Tricare
  • United Healthcare
  • UPMC HMO,PPO ReadingHspEmpONLY
  • UPMC Medicare HMO
  • US Family Health Plan
  • s Comp

Recent Publications

Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment (Journal of Neuro-Oncology, (2018), 137, 1, (171-177), 10.1007/s11060-017-2709-0)

Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment

Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases

Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas

Fractionated Stereotactic Radiotherapy for Facial Nerve Schwannomas

BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial

Tumor volume threshold for achieving improved conformity in VMAT and Gamma Knife stereotactic radiosurgery for vestibular schwannoma

Cryptococcal ventriculoperitoneal shunt infection

Vorinostat as a radiosensitizer for brain metastasis: A phase i clinical trial

Cancer of the Central Nervous System

Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: Age, cochlear dose, and tumor coverage

Clinically silent somatotroph adenomas are common

Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging

Biodistribution and dosimetry of 18F-EF5 in cancer patients with preliminary comparison of 18F-EF5 uptake versus EF5 binding in human glioblastoma

Concurrent cochlear implantation with resection of skull base hemangiopericytoma following sudden deafness in an only hearing ear

Poor drug distribution as a possible explanation for the results of the PRECISE trial

Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas: Clinical investigative study

The relationship among hypoxia, proliferation, and outcome in patients with de nouo glioblastoma: A pilot study

Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status

Hypoxia in brain tumors: A review of the literature